Rheologics Blood Viscosity Test Aspires To Predict Heart Attack, Stroke
This article was originally published in The Gray Sheet
Executive SummaryRheologics envisions the alternative care market as a preliminary step towards building clinical acceptance for its Rheolog whole blood viscosity diagnostic as a tool for treating atherosclerosis
You may also be interested in...
Vydaqel saw its uptake take off in the US last year. UK’s NICE to pass judgement on cost effectiveness by June.
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.
Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect.